Literature DB >> 16586541

Cerebral processing of auditory stimuli in patients with irritable bowel syndrome.

Viola Andresen1, Alexander Poellinger, Chedwa Tsrouya, Dominik Bach, Albrecht Stroh, Annette Foerschler, Petra Georgiewa, Marco Schmidtmann, Ivo R van der Voort, Peter Kobelt, Claus Zimmer, Bertram Wiedenmann, Burghard F Klapp, Hubert Monnikes.   

Abstract

AIM: To determine by brain functional magnetic resonance imaging (fMRI) whether cerebral processing of non-visceral stimuli is altered in irritable bowel syndrome (IBS) patients compared with healthy subjects. To circumvent spinal viscerosomatic convergence mechanisms, we used auditory stimulation, and to identify a possible influence of psychological factors the stimuli differed in their emotional quality.
METHODS: In 8 IBS patients and 8 controls, fMRI measurements were performed using a block design of 4 auditory stimuli of different emotional quality (pleasant sounds of chimes, unpleasant peep (2000 Hz), neutral words, and emotional words). A gradient echo T2*-weighted sequence was used for the functional scans. Statistical maps were constructed using the general linear model.
RESULTS: To emotional auditory stimuli, IBS patients relative to controls responded with stronger deactivations in a greater variety of emotional processing regions, while the response patterns, unlike in controls, did not differentiate between distressing or pleasant sounds. To neutral auditory stimuli, by contrast, only IBS patients responded with large significant activations.
CONCLUSION: Altered cerebral response patterns to auditory stimuli in emotional stimulus-processing regions suggest that altered sensory processing in IBS may not be specific for visceral sensation, but might reflect generalized changes in emotional sensitivity and affective reactivity, possibly associated with the psychological comorbidity often found in IBS patients.

Entities:  

Mesh:

Year:  2006        PMID: 16586541      PMCID: PMC4124347          DOI: 10.3748/wjg.v12.i11.1723

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

1.  Altered processing of acoustic stimuli during sleep: reduced auditory activation and visual deactivation detected by a combined fMRI/EEG study.

Authors:  Michael Czisch; Thomas C Wetter; Christian Kaufmann; Thomas Pollmächer; Florian Holsboer; Dorothee P Auer
Journal:  Neuroimage       Date:  2002-05       Impact factor: 6.556

2.  Phobic anxiety changes the function of brain-gut axis in irritable bowel syndrome.

Authors:  S Blomhoff; S Spetalen; M B Jacobsen; U F Malt
Journal:  Psychosom Med       Date:  2001 Nov-Dec       Impact factor: 4.312

3.  Intestinal reactivity to words with emotional content and brain information processing in irritable bowel syndrome.

Authors:  S Blomhoff; S Spetalen; M B Jacobsen; M Vatn; U F Malt
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

Review 4.  Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?

Authors:  William E Whitehead; Olafur Palsson; Kenneth R Jones
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

5.  Hypersensitivity to visceral and cutaneous pain in the irritable bowel syndrome.

Authors:  Nicholas G Verne; Michael E Robinson; Donald D Price
Journal:  Pain       Date:  2001-07       Impact factor: 6.961

6.  Amitriptyline reduces rectal pain related activation of the anterior cingulate cortex in patients with irritable bowel syndrome.

Authors:  V Morgan; D Pickens; S Gautam; R Kessler; H Mertz
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

7.  Amygdala response to fearful faces in anxious and depressed children.

Authors:  K M Thomas; W C Drevets; R E Dahl; N D Ryan; B Birmaher; C H Eccard; D Axelson; P J Whalen; B J Casey
Journal:  Arch Gen Psychiatry       Date:  2001-11

Review 8.  V. Stress and irritable bowel syndrome.

Authors:  E A Mayer; B D Naliboff; L Chang; S V Coutinho
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-04       Impact factor: 4.052

9.  Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention.

Authors:  H Mertz; V Morgan; G Tanner; D Pickens; R Price; Y Shyr; R Kessler
Journal:  Gastroenterology       Date:  2000-05       Impact factor: 22.682

10.  Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation.

Authors:  B D Naliboff; S W Derbyshire; J Munakata; S Berman; M Mandelkern; L Chang; E A Mayer
Journal:  Psychosom Med       Date:  2001 May-Jun       Impact factor: 4.312

View more
  5 in total

Review 1.  The psyche and the gut.

Authors:  Paul Enck; Ute Martens; Sibylle Klosterhalfen
Journal:  World J Gastroenterol       Date:  2007-07-07       Impact factor: 5.742

2.  Olfactory and gustatory function in irritable bowel syndrome.

Authors:  Silke Steinbach; Wolfgang Reindl; Claudia Kessel; Roland Ott; Thomas Zahnert; Walter Hundt; Petra Heinrich; Dieter Saur; Wolfgang Huber
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-12-30       Impact factor: 2.503

3.  Multivariate morphological brain signatures predict patients with chronic abdominal pain from healthy control subjects.

Authors:  Jennifer S Labus; John D Van Horn; Arpana Gupta; Mher Alaverdyan; Carinna Torgerson; Cody Ashe-McNalley; Andrei Irimia; Jui-Yang Hong; Bruce Naliboff; Kirsten Tillisch; Emeran A Mayer
Journal:  Pain       Date:  2015-08       Impact factor: 7.926

4.  Psychological characteristics and GoNogo research of patients with functional constipation.

Authors:  Xiaoyi Li; Rui Feng; Hao Wu; Lei Zhang; Lan Zhao; Ning Dai; Enyan Yu
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

Review 5.  How to Perform and Interpret Functional Magnetic Resonance Imaging Studies in Functional Gastrointestinal Disorders.

Authors:  In-Seon Lee; Hubert Preissl; Paul Enck
Journal:  J Neurogastroenterol Motil       Date:  2017-04-30       Impact factor: 4.924

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.